ICHOM Patient Centered Outcomes Measure Set for Breast Cancer
1.0.0 - trial-use International flag

This page is part of the ICHOM FHIR Implementation Guide: Breast Cancer (v1.0.0: STU 1) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions

ValueSet: HER2 receptor status ValueSet

Official URL: http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/HER2ReceptorStatusVS Version: 1.0.0
Standards status: Trial-use Maturity Level: 2 Computable Name: HER2ReceptorStatusVS

Copyright/Legal: This value set includes content from SNOMED CT, which is copyright © 2002+ International Health Terminology Standards Development Organisation (IHTSDO), and distributed by agreement between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this agreement

Valueset of the HER2 receptor status

References

Logical Definition (CLD)

 

Expansion

This value set contains 4 concepts

Expansion based on SNOMED CT International edition 31-Jul 2023

CodeSystemDisplay
  431396003http://snomed.info/sctHuman epidermal growth factor 2 negative carcinoma of breast
  427685000http://snomed.info/sctHuman epidermal growth factor 2 positive carcinoma of breast
  280414007http://snomed.info/sctEquivocal result
  416237000http://snomed.info/sctProcedure not done

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code